Invention Grant
- Patent Title: Selective antisense compounds and uses thereof
-
Application No.: US14765633Application Date: 2014-02-04
-
Publication No.: US10260069B2Publication Date: 2019-04-16
- Inventor: Michael Oestergaard , Punit P. Seth , Eric E. Swayze
- Applicant: Ionis Pharmaceuticals, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee: Ionis Pharmaceuticals, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: McNeill Baur PLLC
- International Application: PCT/US2014/014722 WO 20140204
- International Announcement: WO2014/121287 WO 20140807
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113 ; C07H21/02

Abstract:
The present disclosure provides oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell. In certain embodiments, certain oligomeric compounds selectively reduce the expression of a target nucleic acid transcript relative to a non-target nucleic acid transcript.
Public/Granted literature
- US20150376625A1 SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Public/Granted day:2015-12-31
Information query
IPC分类: